Waldencast Acquisition

Yahoo Finance • 2 months ago

Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

NEW YORK and SUNSET BEACH, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), to... Full story

Yahoo Finance • 2 months ago

Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), continues... Full story

Yahoo Finance • 3 months ago

IBN Named Official Media Partner of Octane’s Aesthetics Tech Forum 2026

InvestorBrandNetwork (IBN) AUSTIN, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- IBN (“InvestorBrandNetwork”), a cutting-edge corporate communications firm and content distributor, is pleased to announce that it will serve as an official media... Full story

Yahoo Finance • 4 months ago

Waldencast reports Q2 results; updates FY outlook

* Waldencast press release [https://seekingalpha.com/pr/20317944-waldencast-announces-q2-2025-results-and-provides-q3-2025-trading-update] (WALD [https://seekingalpha.com/symbol/WALD]): Q2 Revenue of $66.83M (+5.6% Y/Y) beats by $0.18M.... Full story

Yahoo Finance • 4 months ago

Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025 net revenue growth driven by U.S. channel expansion and sell-out acceleration but softer... Full story

Yahoo Finance • 4 months ago

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the recent American Soci... Full story

Yahoo Finance • 5 months ago

Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it had sold its rights to the “Obagi” trademark in Japan... Full story

Yahoo Finance • 5 months ago

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

LONDON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided additional details for its upcoming earnings release and conference call dates. The Comp... Full story

Yahoo Finance • 7 months ago

Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi® saypha® MagIQ™ injectable... Full story

Yahoo Finance • 7 months ago

Waldencast price target lowered to $3 from $4 at Telsey Advisory

Telsey Advisory lowered the firm’s price target on Waldencast (WALD) to $3 from $4 and keeps an Outperform rating on the shares. The moderated annual outlook comes as a disappointment as solid underlying trends are offset by softening inte... Full story

Yahoo Finance • 7 months ago

Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand’s Addressable Market in the U.S. Milk Makeup Delivers Strong Retail Sales Performance in U.S. Retail in H1 2025 and... Full story

Yahoo Finance • 8 months ago

Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels

Waldencast plc (NASDAQ:WALD) is one of the Best 52-Week Low Penny Stocks to Buy Now. On July 23, Waldencast plc (NASDAQ:WALD) announced the acquisition of Novaestiq Corp. and the US rights to the Saypha line of hyaluronic acid injectable g... Full story

Yahoo Finance • 8 months ago

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Acquisition strengthens Obagi Medical’s product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence LONDON, July 23, 2025... Full story

Yahoo Finance • 11 months ago

Waldencast price target lowered to $4 from $5 at Telsey Advisory

Telsey Advisory analyst Dana Telsey lowered the firm’s price target on Waldencast (WALD) to $4 from $5 and keeps an Outperform rating on the shares. While not entirely unexpected, FY25 has started out relatively challenging, the analyst te... Full story

Yahoo Finance • 11 months ago

Waldencast Reports Q1 2025 Financial Results

Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 2024 76.4% Adjusted Gross Margin, an improvement of 10 basis points $4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Walde... Full story

Yahoo Finance • 11 months ago

Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast

LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 conference call and webcast. As previously a... Full story

Yahoo Finance • 11 months ago

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Obagi Medic... Full story

Yahoo Finance • last year

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBIT... Full story

Yahoo Finance • last year

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As... Full story

Yahoo Finance • last year

Waldencast Announces Participation in the 2025 IMCAS World Congress

LONDON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the 2025 International Master Course on Aging Science (IMCAS... Full story